收藏切换
Nucleic acid-based PROTACs: emerging strategies and future perspectives
收藏切换
Jian-fei XU, Zhao-peng YAN, Dong-yang GUO, Qian WANG, Jing WANG, Xin-jing TANG*
Acta Pharmaceutica Sinica | 2025, 60(11) : 3283 - 3296
Less
收藏切换
Acta Pharmaceutica Sinica | 2025, 60(11): 3283-3296
• Special Reports: Recent advances in targeted protein degradation therapeutics •
Nucleic acid-based PROTACs: emerging strategies and future perspectives
Full
Jian-fei XU, Zhao-peng YAN, Dong-yang GUO, Qian WANG, Jing WANG, Xin-jing TANG*
Affiliations
  • State Key Laboratory of Natural and Biomimetic Drugs, Chemical Biology Center and School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
Published: 2025-11-12 doi: 10.16438/j.0513-4870.2025-0456
Outline
收藏切换

Targeted protein degradation (TPD) technology achieves selective degradation of target proteins through the ubiquitin-proteasome system (UPS) or lysosomal pathways. Among TPD strategies, proteolysis-targeting chimeras (PROTACs) have emerged as a transformative approach in innovative drug discovery, offering unique advantages such as the ability to target "undruggable" proteins, catalytic degradation kinetics, potential to circumvent drug resistance, and high selectivity. However, conventional small-molecule PROTACs depend on ligands binding to target proteins, limiting their effectiveness against molecules without well-defined binding sites, such as transcription factors (TFs) and RNA-binding proteins (RBPs). To overcome this limitation, oligonucleotide-based PROTAC technology has been developed, utilizing sequence-specific nucleic acid recognition to significantly expand the repertoire of degradable targets. This review systematically summarizes recent advances in oligonucleotide-PROTACs, including innovative designs like TF-PROTACs, RNA-PROTACs, G4-PROTACs, and aptamer-PROTACs, along with their therapeutic potentials. We further discuss persisting challenges such as molecular stability and delivery efficiency, and propose future directions for the field. By integrating nucleic acid molecular biology with protein degradation technologies, this interdisciplinary paradigm promises to unlock novel therapeutic strategies for "undruggable" targets and previously intractable diseases.

PROTAC  /  chimeric oligonucleotide  /  transcription factor  /  RNA-binding protein  /  undruggable protein
许建飞, 闫兆鹏, 郭东阳, 王倩, 王静, 汤新景. 基于核酸的PROTAC技术: 新兴策略与未来展望. 药学学报, 2025 , 60 (11) : 3283 -3296 . DOI: 10.16438/j.0513-4870.2025-0456
Jian-fei XU, Zhao-peng YAN, Dong-yang GUO, Qian WANG, Jing WANG, Xin-jing TANG. Nucleic acid-based PROTACs: emerging strategies and future perspectives[J]. Acta Pharmaceutica Sinica, 2025 , 60 (11) : 3283 -3296 . DOI: 10.16438/j.0513-4870.2025-0456
Year 2025 volume 60 Issue 11
252
116
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0456
  • Receive Date:2025-04-22
  • Online Date:2026-09-20
  • Published:2025-11-12
Article Data
Affiliations
History
  • Received:2025-04-22
  • Revised:2025-09-22
Affiliations
    State Key Laboratory of Natural and Biomimetic Drugs, Chemical Biology Center and School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0456
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT